INS and diabetes mellitus: Although patients with insulin-treated diabetes are classically regarded as high-risk with regard to the occurrence of medication errors, in this study no significant differences emerged with respect to medication errors when compared to patients on oral antihyperglycaemic agents alone [15–20].